Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reporting completion of Phase 1/2 studies evaluating a monoclonal antibody therapy for leukemia and lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma

Drugs mentioned

• Monoclonal antibody therapy (unspecified)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Leukemia, Lymphoma | Phase 1, Phase 2 | Status: COMPLETED